These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37689607)

  • 81. [Application of next-generation DNA sequencing for prenatal testing of fetal chromosomal aneuploidies].
    Liu J; Wang H; Xi H; Jia Z; Zhou Y; Wu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Aug; 32(4):533-7. PubMed ID: 26252102
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The performance evaluation of NIPT for fetal chromosome microdeletion/microduplication detection: a retrospective analysis of 68,588 Chinese cases.
    Shen S; Qi H; Yuan X; Gan J; Chen J; Huang J
    Front Genet; 2024; 15():1390539. PubMed ID: 38911296
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
    Badeau M; Lindsay C; Blais J; Nshimyumukiza L; Takwoingi Y; Langlois S; Légaré F; Giguère Y; Turgeon AF; Witteman W; Rousseau F
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011767. PubMed ID: 29125628
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.
    Dar P; Jacobsson B; MacPherson C; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Edwards L; Haeri S; Silver R; Vohra N; Hyett J; Clunie G; Demko Z; Martin K; Rabinowitz M; Flood K; Carlsson Y; Doulaveris G; Malone C; Hallingstrom M; Klugman S; Clifton R; Kao C; Hakonarson H; Norton ME
    Am J Obstet Gynecol; 2022 Aug; 227(2):259.e1-259.e14. PubMed ID: 35085538
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Analysis of 17,428 pregnant women undergoing non-invasive prenatal testing for fetal chromosome in Northeast China.
    Dai R; Yu Y; Zhang H; Li L; Jiang Y; Liu R; Zhang H
    Medicine (Baltimore); 2021 Feb; 100(6):e24740. PubMed ID: 33578623
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Application of the BACs-on-Beads™ assay for rapid prenatal detection application of BoBs™ for PND of aneuploidies and microdeletions.
    Huang H; Zhang M; Wang Y; Lin N; He D; Chen M; Chen L; Lin Y; Xu L
    Mol Reprod Dev; 2018 Feb; 85(2):146-154. PubMed ID: 29247566
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Retrospective analysis of 44 578 pregnancies undergoing non-invasive prenatal testing in Weifang].
    Xu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1065-1068. PubMed ID: 32924102
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Expanded noninvasive prenatal testing for fetal aneuploidy and copy number variations and parental willingness for invasive diagnosis in a cohort of 18,516 cases.
    Ge Y; Li J; Zhuang J; Zhang J; Huang Y; Tan M; Li W; Chen J; Zhou Y
    BMC Med Genomics; 2021 Apr; 14(1):106. PubMed ID: 33853619
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
    Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Molecular biology usefulness for rapid diagnosis of Down's syndrome and common aneuploidies].
    Fauret AL; Bilan F; Patri S; Couet D; Marechaud M; Pierre F; Gilbert-Dussardier B; Kitzis A
    Gynecol Obstet Fertil; 2009; 37(7-8):611-9. PubMed ID: 19574080
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A cross-sectional survey of pregnant women's knowledge of chromosomal aneuploidy and microdeletion and microduplication syndromes.
    Yang J; Chen M; Ye X; Chen F; Li Y; Li N; Wu W; Sun J
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():82-90. PubMed ID: 33176246
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical performance of non-invasive prenatal testing for trisomies 21, 18 and 13 in twin pregnancies: A cohort study and a systematic meta-analysis.
    He Y; Wang Y; Li Z; Chen H; Deng J; Huang H; He X; Zeng W; Liu M; Huang B; Chen P
    Acta Obstet Gynecol Scand; 2020 Jun; 99(6):731-743. PubMed ID: 32166736
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome.
    Xiao G; Zhao Y; Huang W; Hu L; Wang G; Luo H
    PLoS One; 2022; 17(4):e0266718. PubMed ID: 35421148
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Non-invasive prenatal testing (NIPT) in twin pregnancies affected by early single fetal demise: A systematic review of NIPT and vanishing twins.
    van Eekhout JCA; Bekker MN; Bax CJ; Galjaard RH
    Prenat Diagn; 2023 Jun; 43(7):829-837. PubMed ID: 37226326
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The potential impact of NIPT as a second-tier screen on the outcomes of high-risk pregnancies with rare chromosomal abnormalities.
    Maxwell S; Dickinson JE; Murch A; O'Leary P
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):420-6. PubMed ID: 26286670
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Audit of the first > 7500 noninvasive prenatal aneuploidy tests in a Swiss genetics center.
    Bajka A; Bajka M; Chablais F; Burkhardt T
    Arch Gynecol Obstet; 2022 May; 305(5):1185-1192. PubMed ID: 34533609
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Efficiency of Noninvasive Prenatal Testing for Sex Chromosome Aneuploidies.
    Shi Y; Li X; Ju D; Li Y; Zhang X; Zhang Y
    Gynecol Obstet Invest; 2021; 86(4):379-387. PubMed ID: 34384080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.